Abstract
An anchorage-dependent Wilms tumor cell line HFWT was found to stimulate selective and remarkable expansion of human natural killer (NK) cells from human peripheral blood mononuclear cells (PBMC). After PBMC of healthy donors were cultured on irradiated HFWT cells for 10 - 21 days, the lymphocytes expanded 58- to 401-fold. This NK cell expansion required direct contact of PBMC with live, but not fixed, HFWT cells. The PBMC from an end-stage brain tumor patient also expanded 156-fold, whereas those cultured with irradiated NK-sensitive K562 grew only 30.5-fold. CD16+ CD56+ NK cells accounted for more than 70% of the population expanded on HFWT cells. No essential difference in expression of NK receptors was observed in the expanded NK cells on HFWT and K562 and without feeder cells. The expanded NK cells killed not only fresh HFWT cells but, unexpectedly, also MHC class I-expressing autologous brain tumor cells at an effector/target ratio of 4 for 24 h. These results will contribute to the development of a large-scale preparation method for human NK cells, which will aid studies of NK cell biology and possible treatment of brain tumors.
References
Jan 1, 1992·Cancer Immunology, Immunotherapy : CII·K KawaiT Ohno
Jul 1, 1991·Cellular Immunology·H RabinowichT L Whiteside
Jan 1, 1991·Experimental Pathology·I IshiwataH Ishikawa
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K J EinspahrP J Leibson
Jun 1, 1985·The Journal of Experimental Medicine·J H Phillips, L L Lanier
Nov 16, 1995·Nature·J E Gumperz, P Parham
Mar 1, 1995·Nature Medicine·S Q LiuT Ohno
Oct 1, 1995·European Journal of Immunology·M DüchlerE Hofer
Aug 1, 1993·The Journal of Experimental Medicine·A MorettaL Moretta
Feb 17, 1997·The Journal of Experimental Medicine·A G BrooksJ E Coligan
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·A PorgadorJ L Strominger
May 23, 1998·Annual Review of Immunology·L L Lanier
Oct 13, 1998·Cancer Immunology, Immunotherapy : CII·C KimT Ohno
Jul 3, 1999·Japanese Journal of Cancer Research : Gann·H TsurushimaT Ohno
Apr 27, 2000·Immunology Today·A MorettaL Moretta
Dec 16, 2000·Lancet·K ImaiK Nakachi
Mar 29, 2001·Nature Immunology·L L Lanier
Jun 1, 2001·European Journal of Immunology·G M SpaggiariA Poggi
Citations
Mar 10, 2005·Blood·Chihaya ImaiDario Campana
Feb 15, 2012·Immunotherapy·Shatha FarhanStefan O Ciurea
Dec 29, 2015·Microbiology and Immunology·Shinichiro HattoriSeiji Okada
Oct 28, 2008·International Immunopharmacology·Ru ZhouJian-Ping Zuo
Apr 7, 2009·British Journal of Haematology·Hiroyuki FujisakiDario Campana
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Eiichi IshikawaTadao Ohno
Jul 13, 2004·Experimental Hematology·Hideki HaradaTadao Ohno
Jun 22, 2014·Cytotherapy·Dong-Pyo LimDuck Cho
Jan 17, 2013·Cytotherapy·Eun-Kyung KimDae Seog Heo
Jul 15, 2015·BioMed Research International·Senthamil R Selvan, John P Dowling
Oct 16, 2012·International Immunopharmacology·Xuewen DengAndrew Nicol
Oct 25, 2014·Cancer Immunology, Immunotherapy : CII·Nadia PeragineRobin Foà
Jul 14, 2007·European Journal of Immunology·Hideki HaradaSeiji Okada
Nov 24, 2005·European Journal of Immunology·Hideki HaradaSeiji Okada
Nov 25, 2003·BJU International·T OikawaH Akaza
May 5, 2009·The Korean journal of laboratory medicine·Duck Cho, Dario Campana
Oct 18, 2014·Blood Research·Duk Seong Bae, Jae Kwon Lee
Feb 15, 2019·Immunotherapy·Seon-Hee KimBeom K Choi
Jan 15, 2004·Cancer Science·Eiichi IshikawaTadao Ohno
Jun 14, 2013·Oncology Letters·Baskar SubramaniTerunuma Hiroshi
May 12, 2017·Frontiers in Immunology·Markus GranzinEvelyn Ullrich
Sep 17, 2004·Human Cell·Hideki HaradaTadao Ohno
May 5, 2011·Canadian Journal of Physiology and Pharmacology·T P Hamsa, Girija Kuttan
Feb 16, 2021·Frontiers in Immunology·Keven HoersterStefan Heinrichs